menu
    • menu

    Company profile for Vyriad

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami. The Company has exclusive licenses to technologies discovered and validated at the Department o...
    Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami. The Company has exclusive licenses to technologies discovered and validated at the Department of Molecular Medicine that Vyriad CEO Dr. Stephen Russell founded at Mayo Clinic, along with its comprehensive oncolytic virotherapy program.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VyriadUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2900 37th Street NW Building 110 Rochester, MN 55901
    Telephone
    Telephone
    507-289-0944
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vyriad.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vyriad, Weizmann Sign License Pact For Gene Delivery Technology
    Vyriad, Weizmann Sign License Pact For Gene Delivery Technology

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/vyriad-and-weizmann-institute-of-science-enter-exclusive-license-agreement-for-in-vivo-gene-delivery

    PHARMAWEB
    02 Sep 2025
    Share Share
    Novartis taps Vyriad’s viral vectors for in vivo T cell editing
    Novartis taps Vyriad’s viral vectors for in vivo T cell editing

    20 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/novartis-taps-vyriads-viral-vectors-develop-vivo-t-cell-editing

    FIERCE BIOTECH
    20 Nov 2024
    Share Share
    Vyriad Partners with Novartis to Develop In Vivo CAR-T Therapies
    Vyriad Partners with Novartis to Develop In Vivo CAR-T Therapies

    20 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vyriad-announces-strategic-collaboration-with-novartis-to-develop-in-vivo-car-t-cell-therapies-302310717.html

    PR NEWSWIRE
    20 Nov 2024
    Share Share
    Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic
    Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    14 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vyriad-announces-expansion-of-t-cell-lymphoma-trial-at-mayo-clinic-301850871.html

    PR NEWSWIRE
    14 Jun 2023
    Share Share
    Vyriad, Inc. Appoints Scott Beck as Chief Operating Officer
    Vyriad, Inc. Appoints Scott Beck as Chief Operating Officer

    13 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/vyriad-inc-appoints-scott-beck-as-chief-operating-officer-301622449.html

    PRNEWSWIRE
    13 Sep 2022
    Share Share
    Regeneron-backed oncolytic virus startup scores modest Series B extension
    Regeneron-backed oncolytic virus startup scores modest Series B extension

    18 May 2022

    // P. Schloesser ENDPTS

    https://endpts.com/regeneron-backed-oncolytic-virus-startup-scores-modest-series-b-extension/

    P. Schloesser ENDPTS
    18 May 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search